US$ 21.90
glp 1 inhibitor drugs New GLP-1 Guidelines for Type 2 Diabetes in 2025 Frontiers | Clinical Use of
Description
no major safety concerns were observed

Find the Best Option for Your Weight Management Goals.

With drugs like Ozempic and Wegovy growing in popularity among diabetic patients, CRNAs must be aware of all potential GLP-1 and anesthesia conflicts.

The results of a Phase II clinical trial have demonstrated significant weight reduction in overweight and obese adults

### Competing Interest Statement ASK, AMM, MCG, JMD, CB, CL, SWB, DJL, PML, DRD, JMC, JPF, YL, ARS, DAT, DWP, SH, RBR, MSL, and DAG are employees and stockholders of Pfizer Inc

GLP-1 receptor agonists are medications used to manage obesity and type 2 diabetes
